|
CA101653A
(en)
|
1906-08-30 |
1906-10-23 |
Herman Besser |
Mould
|
|
US3933797A
(en)
*
|
1972-02-22 |
1976-01-20 |
Pfizer Inc. |
6-[α-(ω-QUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS
|
|
BE794886A
(fr)
*
|
1972-02-22 |
1973-08-02 |
Pfizer |
Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques
|
|
US3972872A
(en)
|
1974-09-23 |
1976-08-03 |
Pfizer Inc. |
6-[α-(ω-Guanidinoalkanoylamido)acylamido]penicillanic acids
|
|
HU203221B
(en)
|
1986-09-10 |
1991-06-28 |
Syntex Inc |
Process for selective amidation of diamines
|
|
US5676978A
(en)
*
|
1989-02-14 |
1997-10-14 |
Amira, Inc. |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
|
|
CA2028593C
(en)
*
|
1989-10-31 |
2007-08-21 |
Douglas R. Brandt |
Stabilized enzyme compositions
|
|
DE4334639A1
(de)
|
1993-10-11 |
1995-04-13 |
Inst Neue Mat Gemein Gmbh |
Verfahren zur Herstellung von TiN-Sinterkörpern und -Schichten
|
|
DE793646T1
(de)
*
|
1994-11-23 |
1999-12-30 |
Pharmacia & Upjohn Co., Kalamazoo |
Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus
|
|
US5994577A
(en)
|
1994-11-23 |
1999-11-30 |
Larsen; Scott D. |
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
|
|
JP3745439B2
(ja)
|
1995-07-06 |
2006-02-15 |
花王株式会社 |
皮膚外用剤
|
|
TW453881B
(en)
|
1995-10-16 |
2001-09-11 |
Kao Corp |
Cosmetic composition comprising amide derivatives
|
|
JPH09202710A
(ja)
*
|
1995-11-20 |
1997-08-05 |
Kao Corp |
しわ改善剤
|
|
AU3117497A
(en)
|
1996-05-21 |
1997-12-09 |
Pharmacia & Upjohn Company |
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
|
|
JP4317599B2
(ja)
|
1996-06-26 |
2009-08-19 |
武田薬品工業株式会社 |
徐放性製剤
|
|
AU754740B2
(en)
|
1998-06-30 |
2002-11-21 |
Takeda Chemical Industries Ltd. |
Pharmaceutical composition for the treatment of diabetes
|
|
EP1656945A1
(en)
|
1999-06-05 |
2006-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pharmaceutical composition comprising oligoarginine
|
|
ATE356629T1
(de)
|
1999-06-05 |
2007-04-15 |
Univ Leland Stanford Junior |
Methode und zusammensetzung zur inhibierung von kardiovaskulärer zellproliferation
|
|
US6242491B1
(en)
|
1999-06-25 |
2001-06-05 |
Rima Kaddurah-Daouk |
Use of creatine or creatine compounds for skin preservation
|
|
US20020082448A1
(en)
|
1999-11-08 |
2002-06-27 |
The Upjohn Company |
Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
|
|
WO2003013574A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co., Inc. |
Melanin-concentrating hormone antagonists
|
|
JP2005518346A
(ja)
|
2001-11-07 |
2005-06-23 |
メディカル リサーチ カウンセル |
ドパミン作動性ニューロンの調節
|
|
JP2005527491A
(ja)
|
2002-01-09 |
2005-09-15 |
メルク エンド カムパニー インコーポレーテッド |
選択的メラニン凝集ホルモンタイプ−１受容体アゴニスト
|
|
US20120245211A1
(en)
|
2002-06-04 |
2012-09-27 |
Children's Hospital Medical Center |
Methods of Treating Cognitive Dysfunction by Modulating Brain Energy Metabolism
|
|
EP2567705A3
(en)
|
2002-06-04 |
2013-07-03 |
Avicena Group, Inc. |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
|
|
GB0302882D0
(en)
|
2003-02-07 |
2003-03-12 |
Univ Cardiff |
Improvements in or relating to agents for the treatment of cardiovascular dysfunction and weight loss
|
|
EP1746099A1
(en)
|
2004-12-23 |
2007-01-24 |
DeveloGen Aktiengesellschaft |
Mnk1 or Mnk2 inhibitors
|
|
JP4865251B2
(ja)
|
2005-05-09 |
2012-02-01 |
株式会社 資生堂 |
不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物
|
|
WO2007014756A1
(de)
|
2005-08-02 |
2007-02-08 |
Alzchem Trostberg Gmbh |
Flüssig-formulierung auf basis einer guanidinoessigsäure- komponente
|
|
US8748567B2
(en)
|
2006-05-22 |
2014-06-10 |
Children's Medical Center Corporation |
Method for delivery across the blood brain barrier
|
|
WO2008043024A2
(en)
|
2006-10-04 |
2008-04-10 |
Kalypsys, Inc. |
Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease
|
|
AU2007333105A1
(en)
|
2006-12-11 |
2008-06-19 |
Kempharm, Inc. |
Non-standard amino acid conjugates of amphetamine and processes for making and using the same
|
|
DE102007004781A1
(de)
|
2007-01-31 |
2008-08-07 |
Alzchem Trostberg Gmbh |
Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
|
|
WO2008098151A2
(en)
|
2007-02-08 |
2008-08-14 |
Kempharm, Inc. |
Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
|
|
AU2008296012A1
(en)
|
2007-09-07 |
2009-03-12 |
Gencia Corporation |
Mitochondrial compositions and uses thereof
|
|
DE112009000268T5
(de)
|
2008-02-06 |
2011-06-01 |
Helm Ag |
Prasugrel-Salze mit verbesserten Eigenschaften
|
|
FR2940077B1
(fr)
|
2008-12-19 |
2012-07-20 |
Oreal |
Procede de coloration eclaircissante de matieres keratiniques mettant en oeuvre une composition anhydre colorante comprenant un agent alcalin et une composition oxydante.
|
|
FR2940104B1
(fr)
|
2008-12-19 |
2011-08-19 |
Oreal |
Procede de traitement des cheveux mettant en oeuvre une emulsion directe comprenant un agent oxydant et une composition contenant un agent alcalin
|
|
US7927381B2
(en)
|
2008-12-19 |
2011-04-19 |
L'oreal S.A. |
Process for lightening or lightening direct dyeing or oxidation dyeing in the presence of an aqueous composition comprising at least one fatty substance, and device
|
|
JP5866137B2
(ja)
|
2009-04-30 |
2016-02-17 |
ロレアル |
アミノトリアルコキシシランまたはアミノトリアルケニルオキシシラン化合物を含む組成物を用いたヒトケラチン繊維の明色化および／または着色ならびに装置
|
|
WO2011031308A1
(en)
|
2009-09-09 |
2011-03-17 |
Cytokinetics, Incorporated |
Novel combinations
|
|
WO2011033068A1
(en)
|
2009-09-18 |
2011-03-24 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
FR2954160B1
(fr)
|
2009-12-22 |
2012-03-30 |
Oreal |
Composition de coloration ou d'eclaircissement comprenant un corps gras et un polymere amphotere
|
|
CN107714703A
(zh)
|
2009-12-31 |
2018-02-23 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
DE102010012199A1
(de)
|
2010-03-19 |
2011-09-22 |
Fresenius Medical Care Deutschland Gmbh |
Molekular geprägte Polymere für die Eliminierung von Metaboliten
|
|
FR2958161B1
(fr)
|
2010-04-02 |
2012-04-27 |
Oreal |
Procede de traitement des cheveux mettant en oeuvre une emulsion directe comprenant un agent oxydant et une emulsion directe contenant un agent alcalin
|
|
CA2832672A1
(en)
|
2010-04-16 |
2011-10-20 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
|
US20110262359A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
|
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
EP2560486B1
(en)
|
2010-04-21 |
2018-11-21 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
|
|
EP2560490A1
(en)
|
2010-04-21 |
2013-02-27 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
|
|
BR112012026768A2
(pt)
|
2010-04-21 |
2015-09-29 |
Signature Therapeutics Inc |
composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.
|
|
JP2013525484A
(ja)
|
2010-05-03 |
2013-06-20 |
ジェネンテック， インコーポレイテッド |
タンパク質含有製剤の粘度を低減させるために有用な組成物及び方法
|
|
WO2011143534A1
(en)
|
2010-05-13 |
2011-11-17 |
The Mclean Hospital Corporation |
Methods for the treatment of psychiatric disorders
|
|
EP2399885A1
(en)
|
2010-06-22 |
2011-12-28 |
Ulrich Dietz |
Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification
|
|
WO2012024611A1
(en)
|
2010-08-20 |
2012-02-23 |
Natural Alternatives International, Inc. |
Methods of treating sarcopenia and frailty
|
|
WO2012047630A2
(en)
|
2010-09-27 |
2012-04-12 |
Martin Teintze |
N-alkyl or n-aryl substituted guanide and biguanide compounds and methods of their use
|
|
US8765115B2
(en)
|
2010-12-01 |
2014-07-01 |
National Institute of Agrobiological Scienses |
Method of treatment of gastrointestinal disorders with IL-10
|
|
WO2012122412A2
(en)
|
2011-03-09 |
2012-09-13 |
Signature Therapeutics, Inc. |
Compositions for reducing risk of adverse events caused by drug-drug interactions
|
|
JP6148182B2
(ja)
|
2011-03-09 |
2017-06-14 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
複素環式リンカーを有する活性薬剤プロドラッグ
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
WO2012138214A1
(en)
|
2011-04-08 |
2012-10-11 |
Brewster Lizzy Maritza |
Beta-guanidinopropionic acid for the treatment of hypertension
|
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN102850242A
(zh)
*
|
2011-06-27 |
2013-01-02 |
天津天成制药有限公司 |
胍基丙酸硝酸盐的制备方法
|
|
US8427223B2
(en)
|
2011-07-19 |
2013-04-23 |
Lsi Corporation |
Voltage level translator circuit for reducing jitter
|
|
EP2736510B1
(en)
|
2011-07-28 |
2017-03-01 |
Kempharm, Inc. |
Methylphenidate-prodrugs, processes of making and using the same
|
|
RU2639523C2
(ru)
|
2011-10-18 |
2017-12-21 |
Эйлерон Терапьютикс, Инк. |
Пептидомиметические макроциклы и их применение
|
|
FR2983407B1
(fr)
|
2011-12-06 |
2014-01-03 |
Oreal |
Composition aqueuse riche en huile et son utilisation dans un procede de coloration d'oxydation ou de decoloration
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES CROSS-LINKED WITH TRIAZOLE AND THIOETHER
|
|
WO2013123266A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
PL2854764T3
(pl)
|
2012-06-05 |
2019-07-31 |
Neuroderm Ltd |
Kompozycje zawierające apomorfinę i kwasy organiczne oraz ich zastosowania
|
|
CA2877030A1
(en)
|
2012-06-22 |
2013-12-27 |
Basf Se |
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
|
|
CN109793897B
(zh)
|
2012-10-31 |
2022-02-01 |
洛克菲勒大学 |
结肠癌的治疗和诊断
|
|
FR2997846B1
(fr)
|
2012-11-09 |
2023-10-20 |
Oreal |
Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
|
|
WO2014138492A1
(en)
|
2013-03-08 |
2014-09-12 |
Solan, LLC |
Methods for fabricating graphite-based structures and devices made therefrom
|
|
CN103288685B
(zh)
*
|
2013-07-03 |
2015-02-18 |
郭礼强 |
一种3-胍基丙酸的制备方法
|
|
US20170056352A1
(en)
|
2015-08-25 |
2017-03-02 |
Rgenix, Inc. |
PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
|
|
WO2018160178A1
(en)
|
2017-03-01 |
2018-09-07 |
Rgenix, Inc. |
Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
|